Parissa Tabrizian

9PUBLICATIONS
87CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsRegenerative medicine (incl. stem cells)Transplantation immunologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 24, 2026
Expert consensus on clinical trials for use of systemic therapy in patients with hepatocellular carcinoma undergoing surgical and locoregional therapies.

|Nov 25, 2025
Initial Efforts to Stratify Patients and Donors Utilizing Normothermic Machine Preservation of Livers for Transplant.

Kimberly M Feeney, Leonie van Leeuwen, Rachel Todd

|Aug 20, 2025
Treating Donation After Circulatory Death Liver Grafts With Alteplase During Ex Situ Normothermic Machine Perfusion.

Rachel Todd, Leonie van Leeuwen, Andrew Rosowicz

|Mar 05, 2025
Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study.

Beat Moeckli, Charles-Henri Wassmer, Sofia El Hajji

|Jan 14, 2025
Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort study.

Edison Xu, Parissa Tabrizian, Julio Gutierrez

|Apr 07, 2023
Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium.

Benjamin V Tran, Dimitrios Moris, Daniela Markovic

Pageof 2

Frequent Collaborators

4 joint publications

Sander S Florman

2 joint publications

Neil Mehta

2 joint publications

Antonios Arvelakis

2 joint publications

Rachel Todd